marketcaparena
Search

    SPTX

    Seaport Therapeutics, Inc.

    Company overview

    Market capitalization
    $1.15B
    Employees
    58
    Latest publication
    2026-09-29
    About Seaport Therapeutics, Inc.

    Seaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines. The company develops therapeutic candidates for conditions such as depression and anxiety disorders using its proprietary Glyph technology platform. The Glyph platform is designed to enable oral bioavailability, bypass first-pass metabolism, and reduce liver enzyme elevations or hepatotoxicity and other side effects. All therapeutic candidates in development are based on this platform, with research and development activities focused on neuropsychiatric medicines. The company serves clinicians and key opinion leaders in the healthcare and neuropsychiatric medicine sectors. The company was founded in 2024 and is based in Boston, Massachusetts.

    Company website

    Financial statements

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USD
    Total Revenue0USD0USD
    Research Development66,313,000USD25,070,000USD
    Selling General Administrative20,981,000USD27,346,000USD
    Total Operating Expenses87,294,000USD52,416,000USD
    Operating Income-87,294,000USD-52,416,000USD
    Interest Income11,403,000USD5,537,000USD
    Net Interest Income11,403,000USD5,537,000USD
    Income Before Tax-74,108,000USD-46,879,000USD
    Tax Provision773,000USD0USD
    Net Income-74,881,000USD-46,879,000USD
    Net Income From Continuing Ops-74,881,000USD-46,879,000USD
    Reconciled Depreciation1,405,000USD214,000USD
    Total Other Income Expense Net1,783,000USD—
    SourceLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Total Assets441,681,000USD
    Cash And Equivalents64,223,000USD
    Cash And Short Term Investments273,309,000USD
    Short Term Investments209,086,000USD
    Long Term Investments153,951,000USD
    Total Current Assets282,175,000USD
    Other Current Assets8,866,000USD
    Other Non Current Assets454,000USD
    Total Liabilities19,079,000USD
    Total Current Liabilities15,674,000USD
    Other Current Liabilities0USD
    Total Stockholder Equity422,602,000USD
    Total Equity Including Noncontrolling Interest422,602,000USD
    Property Plant Equipment Net5,101,000USD
    Accounts Payable5,705,000USD
    Short Term Debt1,611,000USD
    Common Stock5,000USD
    Retained Earnings-202,117,000USD
    Accumulated Other Comprehensive Income-475,000USD
    SourceDisclosureDeterministicFinal

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USD
    Total Assets249,009,000USD315,777,000USD
    Total Liab341,554,000USD340,626,000USD
    Total Stockholder Equity-92,545,000USD-24,849,000USD
    Capital Stock1,000USD1,000USD
    Retained Earnings-114,109,000USD-39,228,000USD
    Cash46,042,000USD309,099,000USD
    Total Current Assets223,230,000USD310,152,000USD
    Total Current Liabilities12,782,000USD11,149,000USD
    Long Term Investments17,670,000USD0USD
    Short Term Investments169,941,000USD0USD
    Accounts Payable2,007,000USD4,733,000USD
    Property Plant Equipment Net5,225,000USD5,171,000USD
    Property Plant Equipment Gross6,214,000USD6,008,000USD
    Common Stock Shares Outstanding53,027,817shares53,027,817shares
    Non Current Assets Total25,779,000USD5,625,000USD
    Non Current Liabilities Total328,772,000USD329,477,000USD
    Non Currrent Assets Other2,884,000USD454,000USD
    Net Working Capital210,448,000USD299,003,000USD
    Unclassified Current Assets7,247,000USD—
    Unclassified Current Liabilities10,775,000USD6,416,000USD
    Unclassified Non Current Liabilities328,772,000USD329,477,000USD
    Unclassified Equity21,563,000USD14,378,000USD
    SourceLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USD
    Net Income-74,881,000USD-46,879,000USD
    Depreciation1,405,000USD214,000USD
    Stock Based Compensation6,883,000USD14,524,000USD
    Change In Working Capital-7,930,000USD2,512,000USD
    Total Cash From Operating Activities-77,942,000USD-29,629,000USD
    Capital Expenditures-356,000USD-113,000USD
    Free Cash Flow-78,298,000USD-29,742,000USD
    Investments-183,889,000USD0USD
    Total Cash From Financing Activities-873,000USD339,295,000USD
    Issuance Of Capital Stock0USD326,100,000USD
    Change In Cash-263,057,000USD309,553,000USD
    Begin Period Cash Flow309,553,000USD0USD
    End Period Cash Flow46,496,000USD309,553,000USD
    Unclassified Operating Cash Flow-3,419,000USD—
    Unclassified Financing Cash Flow—13,195,000USD
    SourceLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.